Sponsor pipeline

Arsenal Medical, Inc. clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Not applicable
NCT07541404	MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma	Subdural Hematoma	Recruiting	2026-09-30
NCT02880163	REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam	Hemorrhagic Shock	Recruiting	2025-11-10

Get alerts when Arsenal Medical, Inc.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.